HCV NEW INHIBITORS

HCV Progress in Therapy with Novel Sialomimetic-chimeric inhibitors

CoordinatorNational Institute For Chemical Pharmaceutical Research and Development ; DUKE CHEM SA ; THERAPICON ; Aurigon Life Science GmbH ; PHARMA SERV INTERNATIONAL SRL ; 3S PHARMACOLOGICAL CONSULTATION & RES.SRL ; CYATHUS EXQUIRERE PHARMAFORSCHUNGSGMBH ; Università degli Studi del Piemonte Orientale
Grant period2013-10-01 - 2015-09-30
Funding bodyEuropean Union
Call numberFP7-SME-2012
Grant number315322
IdentifierG:(EU-Grant)315322

     

Recent Publications

There are no publications


 Record created 2014-10-20, last modified 2023-02-28



Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)